Singapore, March 21 -- Merchavia, an Israeli investment company specializing in early stage life sciences companies, announces that it is expanding its investments into the diagnostics sector. It will invest in EFA a total of NIS 1 million.

EFA is developing a device for use as an accurate mobile, portable laboratory that can conduct blood counts (CBC) and assist medical staff in making treatment decisions when treating infections, within minutes of taking the patient's blood.

This rapid test approach is expected to aid in making the treatment for infectious diseases more effective, saving lives and costs, and reducing the excessive administering of antibiotics. Additionally, an easy to obtain hemoglobin level would enable screening for...